Arcutis Biotherapeutics, Inc (ARQT)

CIK 1787306 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Arcutis Biotherapeutics, Inc.

Recent SEC filings

FiledFormAccession number
Nov 4, 20263/A0001628280-26-070382
Nov 4, 202640001628280-26-070381
Nov 4, 20268-K0001787306-26-000056
Nov 4, 202630001628280-26-070384
Nov 4, 202640001628280-26-070385
Nov 4, 202640001628280-26-070383
Nov 4, 20261440001628280-26-070283
Nov 4, 202610-Q0001787306-26-000057
Nov 4, 2026424B50001628280-26-070167
Nov 2, 20261440001628280-26-068984
Nov 2, 20261440001628280-26-068986
Nov 2, 20261440001628280-26-068988
Oct 28, 202630001628280-26-067900
Oct 28, 202640001628280-26-067898
Oct 28, 20268-K0001628280-26-067752
Oct 20, 20261440001628280-26-066520
Oct 19, 202640001628280-26-066331
Oct 15, 20261440001628280-26-065989
Oct 5, 2026SCHEDULE 13G/A0002012383-26-003314
Sep 18, 202640001628280-26-062732
Sep 17, 202640001628280-26-062490
Sep 16, 20261440001628280-26-062242
Sep 15, 20261440001628280-26-062042
Sep 10, 202640001628280-26-061444
Sep 8, 20261440001628280-26-060930